Research Critique - Medika Life

Evidence that the newspaper is not sufficiently detached from promoters to provide an open-minded but skeptical perspective that readers should be able to expect.

CONNECT WITH US ON SOCIAL MEDIA

Medika Life is a unique, not-for-profit operating unit of FINN Partners and maintains an independent voice. Authors opinions may not necessarily represent those shared by FINN Partners and content cannot be promotional - rather informational centered on health issues, life science innovation, ecohealth and patient experience.

CATEGORIES

The Future of Cardiovascular Disease Prevention: Insights from Drs. Eric Topol and Pradeep Natarajan

Surprising Connection Found: Missing Teeth At Birth Linked to Cancer Risk

Why It is Imperative We Redefine Mental Illness and How We Treat It

The Remarkable Research Of CAR T Therapy: B Cell Cancers

LATEST

TRENDING

Gabor Maté’s Bizarre Ideas on Connections Between Stress and Disease

A Stunningly Bad Study Claims Social Media Devastates Teen Girls’ Mental Health

Surprises in the Authorship of a Paper About MDMA to Treat PTSD

Depression isn’t Caused by Low Serotonin Level, Are SSRIs still Effective?

Perhaps, A Braver New World

The MDMA-Assisted Therapy for PTSD Study. What You’ll Get Wrong

Is the New York Times a Shill for Promoters of Psychedelics?

Before Looking at the Results of the Paper on MDMA to Treat PTSD…

Why It is Imperative We Redefine Mental Illness and How We Treat It

Surprising Connection Found: Missing Teeth At Birth Linked to Cancer Risk

EDITORS CHOICE

Surprising Connection Found: Missing Teeth At Birth Linked to Cancer Risk

Perhaps, A Braver New World

The Future of Cardiovascular Disease Prevention: Insights from Drs. Eric Topol and Pradeep Natarajan

Is the New York Times a Shill for Promoters of Psychedelics?

CONNECT WITH US ON SOCIAL MEDIA

Compliance

CORPORATE & MEDIA

Popular categories